Inventor · disambiguated record
Yardena Samuels
Also filed as: SAMUELS YARDENA · SAMUELS YARDENA R
10 granted patents·6 pending applications·65 citations·filing 2005–2023
87Inventor score
Files withUNIV JOHNS HOPKINS5YEDA RES & DEV4SAMUELS YARDENA R3PARSONS DONALD WILLIAM1SAMUELS YARDENA1
Top patents by PatentIndex Score
16 records- 0198US10787713B2Mutations of the PIK3CA gene in human cancersUNIV JOHNS HOPKINS·Filed 2020·Granted Sep 29, 2020·15 cites·19 claims
- 0295US10704105B2Mutations of the PIK3CA gene in human cancersUNIV JOHNS HOPKINS·Filed 2017·Granted Jul 7, 2020·13 cites·10 claims
- 0394US8026053B2Mutations of the PIK3CA gene in human cancersUNIV JOHNS HOPKINS·Filed 2005·Granted Sep 27, 2011·23 cites·63 claims
- 0493US10422006B2Mutations of the PIK3CA gene in human cancersUNIV JOHNS HOPKINS·Filed 2014·Granted Sep 24, 2019·13 cites·33 claims
- 0571US11549150B2Treatment of cancers having mutations of the PIK3CA geneUNIV JOHNS HOPKINS·Filed 2019·Granted Jan 10, 2023·0 cites·13 claims
- 0661US8652787B2Use of ERBB4 as a prognostic and therapeutic marker for melanomaSAMUELS YARDENA R·Filed 2009·Granted Feb 18, 2014·0 cites·5 claims
- 0760US2024180966A1T cell receptors directed against ras-derived recurrent neoantigens and methods of identifying sameYEDA RES & DEV·Filed 2023·Application pending·0 cites
- 0858US2011319477A1Mutations of the pik3ca gene in human cancersSAMUELS YARDENA·Filed 2011·Application pending·0 cites
- 0955US2014141431A1Use of erbb4 as a prognostic and therapeutic marker for melanomaUS HEALTH·Filed 2014·Application pending·0 cites
- 1053US9580750B2P13K pathway mutations in cancerPARSONS DONALD WILLIAM·Filed 2006·Granted Feb 28, 2017·1 cites·13 claims
- 1150US11471504B2Combination therapy for the treatment of cancerYEDA RES & DEV·Filed 2018·Granted Oct 18, 2022·0 cites·6 claims
- 1248US2021315983A1Vaccination with cancer neoantigensYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 1346US2023390371A1Anti-tumor immunity induces the presentation of aberrant peptidesSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2021·Application pending·0 cites
- 1445US2022241331A1Identification of recurrent mutated neopeptidesYEDA RES & DEV·Filed 2020·Application pending·0 cites
- 1539US8795964B2GRM3 mutations and use thereof for the diagnosis and treatment of melanomaSAMUELS YARDENA R·Filed 2011·Granted Aug 5, 2014·0 cites·20 claims
- 1638US9157125B2GRIN2A mutations and use thereof for the diagnosis of melanomaSAMUELS YARDENA R·Filed 2012·Granted Oct 13, 2015·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Yardena Samuels files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →